Children at Risk

Children at Risk

Bibliographic Details
Main Authors:	Rebecca S. Beroukhim, MD, Kevin G. Friedman, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	JACC: Case Reports
Subjects:	acute heart failure children COVID-19 MIS-C reduced ejection fraction risk factor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666084920306744

Similar Items

Chronic disease management in heart failure: focus on telemedicine and remote monitoring
by: Paulino Alvarez, et al.
Published: (2021-06-01)

Digoxin and Heart Failure: Are We Clear Yet?
by: Amit Gupta, MD, et al.
Published: (2017-05-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
by: Daniele Masarone, et al.
Published: (2018-11-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Acute Decompensated Heart Failure with Reduced Ejection Fraction: Common Etiological Cause and Predictor of Mortality in the Nepalese Population
by: Rajesh Nepal, et al.
Published: (2020-01-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
by: Michael Lichtenauer, et al.
Published: (2021-05-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Unexpected or Nonsuspected?
by: Carolina Pemberthy, MD, et al.
Published: (2020-05-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy
by: Sri Harsha Onteddu, et al.
Published: (2020-01-01)

Impact of comorbidities in heart failure – prevalence, effect on functional status, and outcome in indian population: A single-center experience
by: Saurabh Mehrotra, et al.
Published: (2019-01-01)

Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease
by: Man Liu, et al.
Published: (2020-09-01)

Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
by: E. F. Pavlysh, et al.
Published: (2019-04-01)

Cushing syndrome cardiomyopathy: an unusual manifestation of small‐cell lung cancer
by: Srinath‐Reddi Pingle, et al.
Published: (2020-10-01)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
by: Amer N. Kadri, et al.
Published: (2018-08-01)

Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report
by: Yuki Asai, et al.
Published: (2021-03-01)

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
by: Bianca Dahlen, et al.
Published: (2021-06-01)

Osimertinib-Induced Cardiomyopathy
by: Shruti R. Patel, MD, et al.
Published: (2020-04-01)

Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid‐range and preserved ejection fraction
by: Tomoya Ueda, et al.
Published: (2019-10-01)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
by: Dan Liu, et al.
Published: (2021-08-01)

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
by: Steven J. Simmonds, et al.
Published: (2020-01-01)

Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction
by: Ning Zhu, et al.
Published: (2018-05-01)

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
by: Susanne Jung, et al.
Published: (2021-04-01)

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
by: Anthony P. Carnicelli, et al.
Published: (2021-09-01)

Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers
by: Madelaire C, et al.
Published: (2020-06-01)

Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China
by: Liang Guo, et al.
Published: (2016-07-01)

ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure with Reduced Ejection Fraction (ADD DAPA trial)
by: Pankaj Jariwala, MD, DNB, DNB, MNAMS, FACC, FSCAI, et al.
Published: (2021-09-01)

Non‐invasive telemonitoring improves outcomes in heart failure with reduced ejection fraction: a study in high‐risk patients
by: Afonso Nunes‐Ferreira, et al.
Published: (2020-12-01)

Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort
by: Juan Carlos López‐Azor, et al.
Published: (2019-12-01)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
by: Gyalai-Korpos I, et al.
Published: (2015-03-01)

Peripartum cardiomyopathy: A contemporary review
by: Akshai Bhandary, et al.
Published: (2018-01-01)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
by: Masoumeh Sadeghi, et al.
Published: (2020-10-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
by: Speranza Rubattu, et al.
Published: (2020-11-01)

Cardiac reverse remodelling and health status in patients with chronic heart failure
by: Kaiming Wang, et al.
Published: (2021-08-01)

Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: an unresolved problem
by: Matteo Beltrami, et al.
Published: (2019-05-01)